The spring has been a painful time for biotechs; they have been caught with fits n' starts since bottoming with the market in early February. Yet these are the growth names that should be leading the stock market higher, and when that doesn't happen money flees quickly. As we see with Regeneron (REGN) the range is pretty much intact and the lows...
Read the full story and get access to the Real Money Pro trading floor.
There's no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.